TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 26 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2014. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $80,000 | +105.1% | 168,550 | +202.7% | 0.00% | – |
| Q3 2016 | $39,000 | -68.8% | 55,690 | -10.8% | 0.00% | – |
| Q2 2016 | $125,000 | +38.9% | 62,409 | +67.6% | 0.00% | – |
| Q1 2016 | $90,000 | -88.1% | 37,244 | -62.3% | 0.00% | – |
| Q4 2015 | $758,000 | -65.2% | 98,848 | -76.0% | 0.00% | -100.0% |
| Q3 2015 | $2,179,000 | +0.1% | 411,746 | +69.7% | 0.00% | 0.0% |
| Q2 2015 | $2,176,000 | +73.2% | 242,682 | +22.1% | 0.00% | – |
| Q1 2015 | $1,256,000 | +327.2% | 198,701 | +293.9% | 0.00% | – |
| Q4 2014 | $294,000 | +81.5% | 50,444 | +113.1% | 0.00% | – |
| Q3 2014 | $162,000 | -86.4% | 23,676 | -71.6% | 0.00% | – |
| Q2 2014 | $1,195,000 | +47.0% | 83,261 | +6.6% | 0.00% | – |
| Q1 2014 | $813,000 | +97.3% | 78,094 | +95.2% | 0.00% | – |
| Q4 2013 | $412,000 | +221.9% | 40,000 | +14.3% | 0.00% | – |
| Q3 2013 | $128,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Managed Accounts LLC | 75,000 | $35,258,000 | 0.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 696,455 | $327,000 | 0.02% |
| Klingman & Associates, LLC | 10,000 | $5,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 76,500 | $36,000 | 0.00% |
| OPPENHEIMER & CO INC | 73,500 | $34,000 | 0.00% |
| Renaissance Technologies | 774,603 | $364,000 | 0.00% |
| Walleye Trading LLC | 6 | $0 | 0.00% |
| Bank of New York Mellon Corp | 16,660 | $8,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,071 | $5,000 | 0.00% |
| SIMPLEX TRADING, LLC | 200 | $0 | 0.00% |